Gaps in US Psychedelic Policy and How to Close Them
JAMA Health Forum November 7, 2025 Caleigh Propes, Katherine Cheung, Matthew D. Eisenberg et al. 4 citations
This Viewpoint discusses how to fill policy gaps surrounding the use of psychedelics to treat mental health and substance use conditions, should they be approved by the US Food and Drug Administration.
DOI: 10.1001/jamahealthforum.2025.4928 (opens in new tab)
Full text (opens in new tab)
Addiction
Mental health
Government linguistics
Public policy
+4